Bavarian Nordic, GSK smallpox deal

Bavarian Nordic (CSE:BAVA) granted exclusive rights to GlaxoSmithKline (LSE:GSK; GSK) to manufacture and market BAVA's Imvamune ( MVA-BN) smallpox vaccine. Under the deal, BAVA will transfer its techn...